Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 417

1.

Sleep, Growth, and Puberty After Two Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.

Malow BA, Findling RL, Schroder CM, Maras A, Breddy J, Nir T, Zisapel N, Gringras P.

J Am Acad Child Adolesc Psychiatry. 2020 Jan 23. pii: S0890-8567(20)30034-4. doi: 10.1016/j.jaac.2019.12.007. [Epub ahead of print]

2.

Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study.

Grondhuis SN, Farmer CA, Arnold LE, Gadow KD, Findling RL, Molina BSG, Kolko DJ, Buchan-Page KA, Rice RR , Jr, Butter EM, Aman MG.

J Child Adolesc Psychopharmacol. 2019 Nov 15. doi: 10.1089/cap.2019.0109. [Epub ahead of print]

PMID:
31730370
3.

Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children.

Lee ES, Kronsberg H, Findling RL.

Child Adolesc Psychiatr Clin N Am. 2020 Jan;29(1):183-210. doi: 10.1016/j.chc.2019.08.009. Epub 2019 Oct 11. Review.

PMID:
31708047
4.

Clinical, cortical thickness and neural activity predictors of future affective lability in youth at risk for bipolar disorder: initial discovery and independent sample replication.

Bertocci MA, Hanford L, Manelis A, Iyengar S, Youngstrom EA, Gill MK, Monk K, Versace A, Bonar L, Bebko G, Ladouceur CD, Perlman SB, Diler R, Horwitz SM, Arnold LE, Hafeman D, Travis MJ, Kowatch R, Holland SK, Fristad MA, Findling RL, Birmaher B, Phillips ML.

Mol Psychiatry. 2019 Dec;24(12):1856-1867. doi: 10.1038/s41380-018-0273-4. Epub 2018 Oct 19.

5.

Psychiatric Diseases in Children and Adolescents.

Cardwell GS, Findling RL, Robb AS.

Handb Exp Pharmacol. 2019 Oct 10. doi: 10.1007/164_2019_262. [Epub ahead of print]

PMID:
31598836
6.

Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder.

Arnold LE, Van Meter AR, Fristad MA, Youngstrom EA, Birmaher BB, Findling RL, Horwitz S, Black SR.

J Child Psychol Psychiatry. 2020 Feb;61(2):175-181. doi: 10.1111/jcpp.13122. Epub 2019 Sep 15.

PMID:
31523819
7.

Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and Adolescents.

Connor DF, Newcorn JH, Saylor KE, Amann BH, Scahill L, Robb AS, Jensen PS, Vitiello B, Findling RL, Buitelaar JK.

J Child Adolesc Psychopharmacol. 2019 Oct;29(8):576-591. doi: 10.1089/cap.2019.0039. Epub 2019 Aug 27.

8.

A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder.

Ceresoli-Borroni G, Liranso T, Brittain ST, Connor DF, Evans CJ, Findling RL, Hwang S, Candler SA, Robb AS, Nasser A, Schwabe S.

J Child Adolesc Psychopharmacol. 2019 Oct;29(8):592-598. doi: 10.1089/cap.2019.0035. Epub 2019 Aug 2.

9.

Developing and Validating a Definition of Impulsive/Reactive Aggression in Youth.

Young AS, Youngstrom EA, Findling RL, Van Eck K, Kaplin D, Youngstrom JK, Calabrese J, Stepanova E, The Lams Consortium.

J Clin Child Adolesc Psychol. 2019 Jul 25:1-17. doi: 10.1080/15374416.2019.1622121. [Epub ahead of print]

PMID:
31343896
10.

Application of the Impulsive Aggression Diary in Adolescents with Attention-Deficit/Hyperactivity Disorder.

Ceresoli-Borroni G, Liranso T, Brittain ST, Connor DF, Evans CJ, Findling RL, Hwang S, Fry N, Candler SA, Robb AS, Saylor KE, Nasser A, Schwabe S.

J Child Adolesc Psychopharmacol. 2019 Oct;29(8):599-607. doi: 10.1089/cap.2018.0089. Epub 2019 Jul 25.

PMID:
31343272
11.

Additional considerations beyond efficacy for lithium in pediatric bipolar disorder.

Sun AY, Findling RL, Stepanova E.

Bipolar Disord. 2019 Sep;21(6):558-559. doi: 10.1111/bdi.12810. Epub 2019 Jul 15. No abstract available.

PMID:
31264283
12.

Safety considerations in the psychopharmacology of pediatric bipolar disorder.

Sun AY, Woods S, Findling RL, Stepanova E.

Expert Opin Drug Saf. 2019 Sep;18(9):777-794. doi: 10.1080/14740338.2019.1637416. Epub 2019 Jul 11. Review.

PMID:
31242784
13.

Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling.

Liu Z, Osipovitch M, Benraiss A, Huynh NPT, Foti R, Bates J, Chandler-Militello D, Findling RL, Tesar PJ, Nedergaard M, Windrem MS, Goldman SA.

Cell Rep. 2019 Jun 25;27(13):3832-3843.e6. doi: 10.1016/j.celrep.2019.05.088.

14.

Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.

Schroder CM, Malow BA, Maras A, Melmed RD, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P.

J Autism Dev Disord. 2019 Aug;49(8):3218-3230. doi: 10.1007/s10803-019-04046-5.

15.

Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study.

Nicol GE, Kolko R, Lenze EJ, Yingling MD, Miller JP, Ricchio AR, Schweiger JA, Findling RL, Wilfley D, Newcomer JW.

J Child Adolesc Psychopharmacol. 2019 Aug;29(6):439-447. doi: 10.1089/cap.2018.0120. Epub 2019 Apr 17.

PMID:
30994376
16.

Appetitive characteristics in children with cystic fibrosis: Questionnaire validation and associations with nutritional status.

Papantoni A, Reinblatt SP, Findling RL, Moran TH, Mogayzel PJ Jr, Carnell S.

Appetite. 2019 Aug 1;139:90-94. doi: 10.1016/j.appet.2019.03.034. Epub 2019 Apr 1.

PMID:
30946864
17.

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD.

Johnson JK, Liranso T, Saylor K, Tulloch G, Adewole T, Schwabe S, Nasser A, Findling RL, Newcorn JH.

J Atten Disord. 2020 Jan;24(2):348-358. doi: 10.1177/1087054719836159. Epub 2019 Mar 29.

PMID:
30924702
18.

Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.

Findling RL, McNamara NK, Pavuluri M, Frazier JA, Rynn M, Scheffer R, Kafantaris V, Robb A, DelBello M, Kowatch RA, Rowles BM, Lingler J, Zhao J, Clemons T, Martz K, Anand R, Taylor-Zapata P.

J Am Acad Child Adolesc Psychiatry. 2019 Feb;58(2):287-296.e4. doi: 10.1016/j.jaac.2018.07.901. Epub 2018 Nov 26.

PMID:
30738555
19.

Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.

Findling RL, Adler LA, Spencer TJ, Goldman R, Hopkins SC, Koblan KS, Kent J, Hsu J, Loebel A.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):80-89. doi: 10.1089/cap.2018.0083. Epub 2019 Jan 29.

PMID:
30694697
20.

A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression.

Robb AS, Schwabe S, Ceresoli-Borroni G, Nasser A, Yu C, Marcus R, Candler SA, Findling RL.

Postgrad Med. 2019 Mar;131(2):129-137. doi: 10.1080/00325481.2019.1574401. Epub 2019 Feb 14. Review.

PMID:
30678534
21.

Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.

Joseph HM, Farmer C, Kipp H, Kolko D, Aman M, McGinley J, Arnold LE, Gadow KD, Findling RL, Molina BSG.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):90-99. doi: 10.1089/cap.2018.0119. Epub 2018 Dec 28.

PMID:
30592635
22.

Drs. Stepanova and Findling Reply.

Stepanova E, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2018 Dec;57(12):978-979. doi: 10.1016/j.jaac.2018.08.011.

PMID:
30522745
23.

Associations between Parental Psychopathology and Sexual Behavior in an Outpatient Psychiatric Sample.

Black SR, Seager I, Meers MR, Arnold LE, Birmaher B, Findling RL, Horwitz SM, Youngstrom EA, Fristad MA.

J Clin Child Adolesc Psychol. 2020 Jan-Feb;49(1):50-59. doi: 10.1080/15374416.2018.1514614. Epub 2018 Oct 30.

PMID:
30376641
24.

Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective.

Findling RL, Stepanova E, Youngstrom EA, Young AS.

Evid Based Ment Health. 2018 Nov;21(4):177-181. doi: 10.1136/eb-2018-102912. Epub 2018 Oct 16. Review.

PMID:
30327338
25.

A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics.

Lee ES, Vidal C, Findling RL.

J Child Adolesc Psychopharmacol. 2018 Nov;28(9):582-605. doi: 10.1089/cap.2018.0037. Epub 2018 Oct 12. Review.

PMID:
30312108
26.

Evidence-Based Assessment from Simple Clinical Judgments to Statistical Learning: Evaluating a Range of Options Using Pediatric Bipolar Disorder as a Diagnostic Challenge.

Youngstrom EA, Halverson TF, Youngstrom JK, Lindhiem O, Findling RL.

Clin Psychol Sci. 2018 Mar;6(2):243-265. doi: 10.1177/2167702617741845. Epub 2017 Dec 8.

27.

Asenapine pharmacokinetics and tolerability in a pediatric population.

Dogterom P, Riesenberg R, de Greef R, Dennie J, Johnson M, Pilla Reddy V, Miltenburg AM, Findling RL, Jakate A, Carrothers TJ, Troyer MD.

Drug Des Devel Ther. 2018 Aug 30;12:2677-2693. doi: 10.2147/DDDT.S171475. eCollection 2018.

28.

Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.

Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P.

J Child Adolesc Psychopharmacol. 2018 Oct 11. doi: 10.1089/cap.2018.0020. [Epub ahead of print]

29.

Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight.

Findling RL, Earley W, Suppes T, Patel M, Wu X, Chang CT, McIntyre RS.

Neuropsychiatr Dis Treat. 2018 Aug 2;14:1941-1952. doi: 10.2147/NDT.S165743. eCollection 2018.

30.

Developing and Validating Short Forms of the Parent General Behavior Inventory Mania and Depression Scales for Rating Youth Mood Symptoms.

Youngstrom EA, Van Meter A, Frazier TW, Youngstrom JK, Findling RL.

J Clin Child Adolesc Psychol. 2018 Jul 24:1-16. doi: 10.1080/15374416.2018.1491006. [Epub ahead of print]

PMID:
30040496
31.

Decreased functional connectivity in the fronto-parietal network in children with mood disorders compared to children with dyslexia during rest: An fMRI study.

Horowitz-Kraus T, Woodburn M, Rajagopal A, Versace AL, Kowatch RA, Bertocci MA, Bebko G, Almeida JRC, Perlman SB, Travis MJ, Gill MK, Bonar L, Schirda C, Diwadkar VA, Sunshine JL, Birmaher B, Axelson D, Gerry Taylor H, Horwitz SM, Frazier T, Eugene Arnold L, Fristad MA, Youngstrom EA, Findling RL, Phillips ML, Holland SK.

Neuroimage Clin. 2018 Mar 1;18:582-590. doi: 10.1016/j.nicl.2018.02.034. eCollection 2018.

32.

Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk.

Versace A, Ladouceur CD, Graur S, Acuff HE, Bonar LK, Monk K, McCaffrey A, Yendiki A, Leemans A, Travis MJ, Diwadkar VA, Holland SK, Sunshine JL, Kowatch RA, Horwitz SM, Frazier TW, Arnold LE, Fristad MA, Youngstrom EA, Findling RL, Goldstein BI, Goldstein T, Axelson D, Birmaher B, Phillips ML.

Neuropsychopharmacology. 2018 Oct;43(11):2212-2220. doi: 10.1038/s41386-018-0083-z. Epub 2018 May 4.

33.

Treating Bipolar Disorder in Adolescents.

Findling RL.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: SU17023TX2C. doi: 10.4088/JCP.SU17023TX2C.

34.

An Examination of Blood Cell Membrane Potential as a Diagnostic Test of Attention Deficit Disorder in Children.

Stepanova E, Findling RL, Kaplin D, Frimpong B, Pikalova S, Young AS.

J Atten Disord. 2018 Apr 1:1087054718772169. doi: 10.1177/1087054718772169. [Epub ahead of print]

PMID:
29707999
35.

The Workforce Shortage of Child and Adolescent Psychiatrists: Is It Time for a Different Approach?

Findling RL, Stepanova E.

J Am Acad Child Adolesc Psychiatry. 2018 May;57(5):300-301. doi: 10.1016/j.jaac.2018.02.008.

PMID:
29706155
36.

An update on pharmacotherapy of autism spectrum disorder in children and adolescents.

Goel R, Hong JS, Findling RL, Ji NY.

Int Rev Psychiatry. 2018 Feb;30(1):78-95. doi: 10.1080/09540261.2018.1458706. Epub 2018 Apr 25. Review.

PMID:
29693461
37.

Improving the Diagnosis and Treatment of Pediatric Bipolar Disorder.

Findling RL, Chang KD.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: su17023ah3c. doi: 10.4088/JCP.su17023ah3c. Epub 2018 Mar 27.

38.

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.

Durgam S, Chen C, Migliore R, Prakash C, Edwards J, Findling RL.

Paediatr Drugs. 2018 Aug;20(4):353-363. doi: 10.1007/s40272-018-0290-4.

39.

Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms.

Salcedo S, Rizvi SH, Freeman LK, Youngstrom JK, Findling RL, Youngstrom EA.

Eur Child Adolesc Psychiatry. 2018 Nov;27(11):1491-1498. doi: 10.1007/s00787-018-1140-1. Epub 2018 Mar 20.

40.

Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.

Stepanova E, Dowling S, Phelps M, Findling RL.

Dialogues Clin Neurosci. 2017 Dec;19(4):395-402. Review.

41.

Diagnostic Accuracy of the CASI-4R Psychosis Subscale for Children Evaluated in Pediatric Outpatient Clinics.

Rizvi SH, Salcedo S, Youngstrom EA, Freeman LK, Gadow KD, Fristad MA, Birmaher B, Kowatch RA, Horwitz SM, Frazier TW, Arnold LE, Taylor HG, Findling RL.

J Clin Child Adolesc Psychol. 2019 Jul-Aug;48(4):610-621. doi: 10.1080/15374416.2017.1410824. Epub 2018 Jan 26.

PMID:
29373050
42.

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.

Atkinson S, Lubaczewski S, Ramaker S, England RD, Wajsbrot DB, Abbas R, Findling RL.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):55-65. doi: 10.1089/cap.2017.0099. Epub 2017 Nov 29.

43.

Psychopharmacology of Bipolar Disorders in Children and Adolescents.

Stepanova E, Findling RL.

Pediatr Clin North Am. 2017 Dec;64(6):1209-1222. doi: 10.1016/j.pcl.2017.08.002. Epub 2017 Oct 4. Review.

PMID:
29173781
44.

Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.

Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2017 Dec;56(12):1026-1033. doi: 10.1016/j.jaac.2017.09.426. Epub 2017 Oct 6.

45.

Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.

Stepanova E, Grant B, Findling RL.

Paediatr Drugs. 2018 Apr;20(2):121-134. doi: 10.1007/s40272-017-0274-9. Review.

46.

Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.

Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):948-957.e4. doi: 10.1016/j.jaac.2017.09.414. Epub 2017 Sep 19.

47.

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.

Findling RL, Robb AS, DelBello MP, Huss M, McNamara NK, Sarkis EH, Scheffer RE, Poulsen LH, Chen G, Lemming OM, Auby P.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):47-54. doi: 10.1089/cap.2017.0047. Epub 2017 Oct 16.

48.

The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.

Goldstein BI, Birmaher B, Carlson GA, DelBello MP, Findling RL, Fristad M, Kowatch RA, Miklowitz DJ, Nery FG, Perez-Algorta G, Van Meter A, Zeni CP, Correll CU, Kim HW, Wozniak J, Chang KD, Hillegers M, Youngstrom EA.

Bipolar Disord. 2017 Nov;19(7):524-543. doi: 10.1111/bdi.12556. Epub 2017 Sep 25. Review.

49.

Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.

Xiao L, Ganocy SJ, Findling RL, Chang K, DelBello MP, Kane JM, Tohen M, Xiang YT, Correll CU.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1158-e1166. doi: 10.4088/JCP.16m10923.

PMID:
28922591
50.

A Multisymptomatic Child With Bipolar Disorder: How to Track and Sequence Treatment.

Post RM, Rowe M, Kaplan D, Findling RL.

Prim Care Companion CNS Disord. 2017 Aug 31;19(4). pii: 17r02122. doi: 10.4088/PCC.17r02122.

Supplemental Content

Loading ...
Support Center